Chronicles of progress: Celebrating 40 years of scientific excellence in diabetes

The 40th anniversary of Diabetes Metabolism Research and Reviews (DMRR) marks a significant milestone in the field, reflecting four decades of continuous dedication to advancing our understanding of diabetes and related metabolic disorders. Over the years, the journal has been a pivotal platform for disseminating groundbreaking research and review articles that have shaped the landscape of diabetes care and research.

One of the noteworthy aspects of the journal is its commitment to historical perspectives, exploring pivotal moments and discoveries that have shaped our understanding of diabetes. This includes insightful articles on ketone bodies, shedding light on their role in diabetes and metabolic health. Additionally, the exploration of latent autoimmune diabetes in adults has undoubtedly contributed to the evolving comprehension of diabetes subtypes, paving the way for more tailored treatment approaches.

The editorial team, led by esteemed individuals such as the first DMRR Editor in Chief Jerry Reaven, deserves commendation for their unwavering commitment to advancing diabetes research. Jerry Reaven, renowned for his discovery of the metabolic syndrome (originally termed Reaven Syndrome), has played a crucial role in shaping our understanding of the interconnectedness of metabolic factors contributing to diabetes and cardiovascular disease.

Domenico Andreani, DMRR Editor in Chief and past president of the European Association for the Study of Diabetes, brought a wealth of experience and a global perspective to the editorial team. His contributions likely reflect a dedication to fostering international collaboration and advancing diabetes research on a broader scale.

Jesse Roth, my predecessor at DMRR as Editor in Chief, is a distinguished researcher who discovered insulin receptors and represents a key figure in the history of diabetes research. The exploration of insulin receptors has been pivotal in unrevealing the intricacies of insulin signalling and has undoubtedly influenced therapeutic strategies for managing diabetes.

As the current DMRR Editor in Chief and the excellent contribution of nine Co-editors, we strive bringing our expertise and insight into the various facets of diabetes research with their clinical perspectives. Our involvement signifies a commitment to fostering a comprehensive understanding of diabetes, encompassing both clinical and research viewpoints.

In 2023, the journal has experienced a remarkable increase in submissions, attesting to its continued relevance and influence in the scientific community. The influx of papers suggests a thriving community of researchers eager to contribute to the ongoing dialogue on diabetes and metabolic diseases.

As the journal celebrates its 40th anniversary, it stands as a tribute to the collaborative efforts of researchers, editors and contributors who have dedicated themselves to advancing our understanding of diabetes and related conditions. Looking ahead, the journal is poised to continue playing a pivotal role in shaping the future of diabetes and metabolic research as well as application to the field of clinical practice.

The author declares no conflicts of interest.